- Home
- PBFS vs AMRN Comparison
PBFS vs AMRN Comparison
Compare PBFS & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBFS
- AMRN
- Stock Information
- Founded
- PBFS 1889
- AMRN 1989
- Country
- PBFS United States
- AMRN Ireland
- Employees
- PBFS N/A
- AMRN N/A
- Industry
- PBFS Banks
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- PBFS Finance
- AMRN Health Care
- Exchange
- PBFS Nasdaq
- AMRN Nasdaq
- Market Cap
- PBFS 329.3M
- AMRN 338.7M
- IPO Year
- PBFS N/A
- AMRN 1993
- Fundamental
- Price
- PBFS $13.25
- AMRN $15.71
- Analyst Decision
- PBFS
- AMRN Strong Sell
- Analyst Count
- PBFS 0
- AMRN 1
- Target Price
- PBFS N/A
- AMRN $12.00
- AVG Volume (30 Days)
- PBFS 15.5K
- AMRN 147.4K
- Earning Date
- PBFS 10-30-2025
- AMRN 10-29-2025
- Dividend Yield
- PBFS N/A
- AMRN N/A
- EPS Growth
- PBFS 16.64
- AMRN N/A
- EPS
- PBFS 0.84
- AMRN N/A
- Revenue
- PBFS $91,717,000.00
- AMRN $226,733,000.00
- Revenue This Year
- PBFS N/A
- AMRN N/A
- Revenue Next Year
- PBFS N/A
- AMRN N/A
- P/E Ratio
- PBFS $15.89
- AMRN N/A
- Revenue Growth
- PBFS 17.04
- AMRN N/A
- 52 Week Low
- PBFS $10.60
- AMRN $7.08
- 52 Week High
- PBFS $13.65
- AMRN $20.90
- Technical
- Relative Strength Index (RSI)
- PBFS 54.43
- AMRN 34.89
- Support Level
- PBFS $13.07
- AMRN $15.03
- Resistance Level
- PBFS $13.40
- AMRN $15.85
- Average True Range (ATR)
- PBFS 0.22
- AMRN 0.96
- MACD
- PBFS 0.01
- AMRN -0.49
- Stochastic Oscillator
- PBFS 61.02
- AMRN 10.73
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.